Septerna SEPN
NASDAQ SEPN
$38.25 +0.20 (+0.53%)
As of: Oct 2, 2026 · 11:45 AM EDT

Septerna (SEPN) Non-Current Deffered Revenue (2025 - 2026)

Updated

Septerna (SEPN) recorded Non-Current Deffered Revenue of $80.04 million in Q2 2026, down 13.2% from the prior quarter.

Analysis

Septerna (SEPN) Non-Current Deffered Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, Septerna reported Non-Current Deffered Revenue of $105.92 million.

  • Per Business Quant, the preceding three quarters came in at $92.18 million (Q1 2026), $105.92 million (Q4 2025) and $120.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Septerna 1.79 Bn 1.79 Bn - 80.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.04 Mn
Mar 31, 2026 92.18 Mn
Dec 31, 2025 105.92 Mn
Sep 30, 2025 120.65 Mn
API Access

Septerna Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SEPN&period=max&api_key=YOUR_API_KEY